Leukine 250 ug/mL
SARGRAMOSTIM · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Partner Therapeutics, Inc.
Leukine (sargramostim) is an injectable medication that stimulates the growth and activity of white blood cells, used to help restore immune function in patients undergoing certain cancer treatments or bone marrow transplants. It belongs to a class of drugs called leukocyte growth factors and is given by intravenous injection.
Key Facts
- Brand Name
- Leukine
- Generic Name
- SARGRAMOSTIM
- NDC Code (Product)
71837-5843- Manufacturer
- Partner Therapeutics, Inc.
- Strength
- 250 ug/mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA103362
- Drug Class
- Leukocyte Growth Factor [EPC]
- Marketing Start
- 09/01/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Leukine used for?
Leukine (sargramostim) is an injectable medication that stimulates the growth and activity of white blood cells, used to help restore immune function in patients undergoing certain cancer treatments or bone marrow transplants. It belongs to a class of drugs called leukocyte growth factors and is given by intravenous injection.
Is Leukine a controlled substance?
Leukine is not classified as a controlled substance by the DEA.
What is the generic name for Leukine?
The generic name for Leukine is SARGRAMOSTIM. There are no other listed brand versions of SARGRAMOSTIM.
What is the NDC code for Leukine 250 ug/mL?
The NDC (National Drug Code) for Leukine 250 ug/mL is 71837-5843, listed by Partner Therapeutics, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)